OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
2411$1.4558

Shenzhen Pagoda Industrial Group Corp Ltd

Food Retail & DistributionVerified

The company's capital structure is characterized by a debt-to-equity ratio of 1.12, indicating a moderate reliance on debt financing. Despite holding CNY 1.95 billion in cash and equivalents, the company's long-term debt of CNY 2.99 billion results in a negative net cash position, raising liquidity concerns. The price-to-book ratio of 1.08 suggests the market values the company close to its book value, while the price-to-tangible-book ratio of 1.08 reflects a similar valuation relative to tangible assets. Profitability metrics reveal significant challenges, with a return on equity (ROE) of -11.84% and a return on assets (ROA) of -4.18%, both well below industry norms. The company reported a net loss of CNY 317.49 million for the period, with operating income also in negative territory at CNY -287.38 million. Gross profit of CNY 597.21 million is insufficient to cover operating expenses, highlighting inefficiencies in cost management. Geographically, the company's revenue is concentrated in its domestic operations, with no disclosed international segments. This lack of diversification increases exposure to local economic and regulatory risks. The company's operating cash flow of CNY -150.08 million and free cash flow of CNY -262.17 million further underscore its inability to generate positive cash from operations. Looking ahead, the company is projected to face continued financial pressure, with no clear path to profitability in the near term. Capital expenditures of CNY -49.60 million indicate ongoing investment, but without a corresponding increase in revenue or margin improvement, these investments may not yield positive returns. The company's liquidity risk is rated as medium, with the key flag of negative net cash after subtracting total debt. Recent filings and transcripts have not revealed any material events that would significantly alter the company's trajectory. The absence of strong buy or hold recommendations from analysts, combined with a mean recommendation of 1.00 (strong buy), suggests a cautious outlook from the investment community. The company's last actual EPS of -0.21 CNY contrasts sharply with the mean EPS estimate of 0.01 CNY, indicating a potential overestimation of future earnings.

30-day price · 2411(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyShenzhen Pagoda Industrial Group Corp Ltd
Ticker2411.HK
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Shenzhen Pagoda Industrial Group Corp Ltd operates in the Food Retail & Distribution industry, primarily generating revenue through the retail and distribution of food and drug products.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a classification confidence of 0.92.

The company's capital structure is characterized by a debt-to-equity ratio of 1.12, indicating a moderate reliance on debt financing. Despite holding CNY 1.95 billion in cash and equivalents, the company's long-term debt of CNY 2.99 billion results in a negative net cash position, raising liquidity concerns. The price-to-book ratio of 1.08 suggests the market values the company close to its book value, while the price-to-tangible-book ratio of 1.08 reflects a similar valuation relative to tangible assets. Profitability metrics reveal significant challenges, with a return on equity (ROE) of -11.84% and a return on assets (ROA) of -4.18%, both well below industry norms. The company reported a net loss of CNY 317.49 million for the period, with operating income also in negative territory at CNY -287.38 million. Gross profit of CNY 597.21 million is insufficient to cover operating expenses, highlighting inefficiencies in cost management. Geographically, the company's revenue is concentrated in its domestic operations, with no disclosed international segments. This lack of diversification increases exposure to local economic and regulatory risks. The company's operating cash flow of CNY -150.08 million and free cash flow of CNY -262.17 million further underscore its inability to generate positive cash from operations. Looking ahead, the company is projected to face continued financial pressure, with no clear path to profitability in the near term. Capital expenditures of CNY -49.60 million indicate ongoing investment, but without a corresponding increase in revenue or margin improvement, these investments may not yield positive returns. The company's liquidity risk is rated as medium, with the key flag of negative net cash after subtracting total debt. Recent filings and transcripts have not revealed any material events that would significantly alter the company's trajectory. The absence of strong buy or hold recommendations from analysts, combined with a mean recommendation of 1.00 (strong buy), suggests a cautious outlook from the investment community. The company's last actual EPS of -0.21 CNY contrasts sharply with the mean EPS estimate of 0.01 CNY, indicating a potential overestimation of future earnings.
Key takeaways
  • The company is operating at a loss with negative operating and net income, indicating significant financial distress.
  • The debt-to-equity ratio of 1.12 and negative net cash position highlight liquidity and solvency risks.
  • Profitability metrics such as ROE and ROA are negative, suggesting poor returns on equity and assets.
  • The company's lack of international diversification increases its exposure to local market risks.
  • Analysts have not issued any buy or hold recommendations, reflecting a cautious outlook on the company's future performance.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$8.17B
Gross profit$597.2M
Operating income-$287.4M
Net income-$317.5M
R&D
SG&A
D&A
SBC
Operating cash flow-$150.1M
CapEx-$49.6M
Free cash flow-$262.2M
Total assets$7.60B
Total liabilities$4.92B
Total equity$2.68B
Cash & equivalents$1.95B
Long-term debt$2.99B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$8.17B-$287.4M-$317.5M-$262.2M
FY-1$10.27B-$341.5M-$386.0M-$559.1M
FY-2$11.39B$416.6M$361.7M$228.8M
FY-3$11.31B$385.0M$323.3M$260.0M
FY-4$10.29B$295.1M$230.3M$295.2M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$7.60B$2.68B$1.95B
FY-1$7.82B$2.71B$1.76B
FY-2$7.59B$3.22B$2.11B
FY-3$6.81B$2.95B
FY-4$6.42B$2.64B
PeriodOCFCapExFCFSBC
FY0-$150.1M-$49.6M-$262.2M
FY-1$164.6M-$218.5M-$559.1M
FY-2-$48.5M-$117.7M$228.8M
FY-3$589.2M-$174.5M$260.0M
FY-4$283.9M-$44.0M$295.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$1.45
Market cap$2.89B
Enterprise value$3.93B
P/E
Reported non-GAAP P/E
EV/Revenue0.5
EV/Op income
EV/OCF
P/B1.1
P/Tangible book1.1
Tangible book$2.68B
Net cash-$1.05B
Current ratio1.4
Debt/Equity1.1
ROA-4.2%
ROE-11.8%
Cash conversion47.0%
CapEx/Revenue-0.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
Metric2411Activity
Op margin-3.5%2.8% medp25 0.9% · p75 5.9%bottom quartile
Net margin-3.9%1.8% medp25 0.3% · p75 3.6%bottom quartile
Gross margin7.3%24.1% medp25 13.8% · p75 31.4%bottom quartile
CapEx / revenue-0.6%-2.0% medp25 -3.8% · p75 -1.0%top quartile
Debt / equity112.0%56.0% medp25 14.0% · p75 113.8%above median
Observations
IR observations
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.01 CNY
Last actual EPS-0.21 CNY
Mean revenue estimate9,232,000,000 CNY
Last actual revenue8,174,438,000 CNY
Mean EBIT estimate92,000,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-19 01:02 UTCJob: 46228886